Cover Page
| Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
| Dec. 31, 2023 | Apr. 26, 2024 | Jun. 30, 2023 | |
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Document Annual Report | true | ||
| Current Fiscal Year End Date | --12-31 | ||
| Document Period End Date | Dec. 31, 2023 | ||
| Document Transition Report | false | ||
| Entity File Number | 001-36421 | ||
| Entity Registrant Name | Aurinia Pharmaceuticals Inc. | ||
| Entity Incorporation, State or Country Code | Z4 | ||
| Entity Address, Address Line One | #140, 14315 - 118 Avenue | ||
| Entity Address, City or Town | Edmonton | ||
| Entity Address, State or Province | AB | ||
| Entity Address, Postal Zip Code | T5L 4S6 | ||
| Entity Tax Identification Number | 98-1231763 | ||
| City Area Code | )(250) | ||
| Local Phone Number | 744-2487 | ||
| Title of 12(b) Security | Common shares, no par value | ||
| Trading Symbol | AUPH | ||
| Security Exchange Name | NASDAQ | ||
| Entity Well-known Seasoned Issuer | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Large Accelerated Filer | ||
| Entity Small Business | false | ||
| Entity Emerging Growth Company | false | ||
| ICFR Auditor Attestation Flag | true | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 1,380 | ||
| Entity Common Stock, Shares Outstanding | 143,019,365 | ||
| Documents Incorporated by Reference | None. | ||
| Amendment Flag | false | ||
| Document Fiscal Year Focus | 2023 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Central Index Key | 0001600620 | ||
| Document Financial Statement Error Correction [Flag] | false |